TY - JOUR T1 - Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C JF - Expert Opin Drug Metab Toxicol Y1 - 2017 A1 - Soriano, V A1 - Benítez-Gutiérrez, L A1 - Arias, A A1 - et, al VL - 13 SP - 1015-1022 IS - 9 ER -